[1]Laburthe M, Couvineau A, Tan V. Class Ⅱ G protein-coupled receptorsfor VIP and PACAP: structure, models of activation and pharmacology[J]. Peptides, 28(9): 1631-1639.
[2]Valdehita A, Carmena M J, Collado B, et al. Vasoactiveintestinal peptide (VIP) increases vascular endothelial growth factor (VEGF) expression and secretion in human breast cancer cells[J]. RegulPept, 144(1-3): 101-108.
[3]Valdehita A, Bajo A M, Schally A V, et al. Vasoactive intestinal peptide (VIP) induces transactivation of EGFR and HER2in human breast cancer cells[J]. Mol Cell Endocrinol, 302(1): 341-348.
[4]Reubi J C, Laderach U, Waser B, et al. Vasoactive intestinal peptide/pituitary adenylatecyclase-activating peptidereceptor subtypes in human tumors and their tissues of origin[J]. Cancer Res, 60(11): 3105-3112.
[5]Reubi J C, Körner M, WaserB,et al. High expression of peptide receptors as a novel target in gastrointestinal stromal tumours[J]. Eur J Nucl Med Mol Imaging, 31(6): 803-810.
[6]Tang Bo, Li Zhexu, Huang Dingde,et al. Screening of a Specific Peptide Binding to VPAC1 Receptor from a Phage Display Peptide Library[J]. Plos One, 2013, 8(1), e54264.
[7]杨远友,廖家莉,林如山,等. 双功能偶联剂SPC 的一种新合成方法及其碘标记[J]. 化学研究与应用,2008,20(2):162-165. Yang Yuanyou, Liao Jiali, Lin Rushan, et al. A new synthesis route for SPC as a bi-functional linker for radioiodination and its labeling of iodine[J]. Chemical Research and Application, 2008, 20(2): 162-165(in Chinese).
[8]唐军,金建南,刘宁,等. 用于放射性砹( 碘) 标记蛋白质的偶联剂 SPC的合成与表征[J]. 原子能科学技术,2004,25(3):261-265. Tang Jun, Jin Jiannan, Liu Ning, et al. Synthesis and characterization of SPC as a linker for labeling proteins with astatine and iodine radioistopes[J]. Atomic Energy Science and Technology, 2004, 25(3): 261-265(in Chinese). |